课题基金 / 基金详情

Regulation of apolipoprotein A-I gene expression by ascorbic acid in scurvy-prone ODS-od/od rats.

Regulation of apolipoprotein A-I gene expression by ascorbic acid in scurvy-prone ODS-od/od rats.
抗坏血酸对易患坏血病的 ODS-od/od 大鼠中载脂蛋白 A-I 基因表达的调节。
批准号:
05660136
负责人:
HORIO Fumihiko
金额:
$1.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1993
资助国家:
日本
项目状态:
已结题
起止时间:
1993 至 1994

项目摘要

项目成果

HORIO Fumihiko的其他基金

相似基金

相关文献

中文摘要
翻译
载脂蛋白a - i (Apo a - i)是血清高密度脂蛋白(HDL)的主要载脂蛋白,它将胆固醇从外周组织转运到肝脏。我们观察到易患坏血病的ODS-od/od大鼠抗坏血酸(AsA)缺乏时血清HDL中的载脂蛋白A-I降低。在这项研究中,我们研究了AsA缺乏导致血清中低水平载脂蛋白a - i的机制。与对照组相比,asa缺乏组肝脏Apo A-I mRNA水平下降(50%),小肠Apo A-I mRNA水平下降(50%)。由于AsA缺乏不影响Apo A-I基因的转录率,因此可能需要AsA来稳定Apo A-I mRNA。此外,与对照组相比,抗坏血酸缺乏大鼠肝脏中白蛋白mRNA水平较低,接触珠蛋白mRNA水平较高,1-酸糖蛋白mRNA水平较高。包括载脂蛋白A-I mRNA在内的肝脏mRNA水平的这些变化也在急性期或炎症期观察到。目前,我们正在测定血清中白细胞介素-6的水平,白细胞介素-6是抗坏血酸缺乏患者急性期和炎症期分泌的主要细胞因子。
英文摘要
Apolipoprotein A-I (Apo A-I) is a major apolipoprotein of serum high density lipoprotein (HDL) , which transports cholesterol from peripheral tissues to liver. We observed that apo A-I in serum HDL was decreased in ascorbic acid (AsA) deficiency in scurvy-prone ODS-od/od rats. In this study, we examined the mechanism how AsA deficiency causes a low level Apo A-I in serum.The Apo A-I mRNA level in the liver but not in the small intestine was decreased (50%) in AsA-deficient group compared to in the control group. As AsA deficiency did not affect the transcription rate of Apo A-I gene, AsA might be required to stabilize Apo A-I mRNA.Moreover, a lower level of albumin mRNA,a higher level of haptoglobin mRNA and a higher level of 1-acid glycoprotein mRNA in the liver was observed in ascorbic acid-deficienct rats compared to in the control rats. These changes in hepatic levels of mRNA including Apo A-I mRNA are also observed in acute phase or inflammation. At present, we are measuring the serum levels of interleukin-6, which is a major cytokine secreted in acute phase and inflammation, in ascorbic acid deficiency.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
Ikeda, S.: "Ascorbate deficiency decreases hepatic apolipoprotein A-I mRNA in a scurvy-prone rat (genotype ODS-od/od)." Biochem.J.(submitted.).
Ikeda, S.:“抗坏血酸缺乏会降低坏血病倾向大鼠(基因型 ODS-od/od)的肝载脂蛋白 A-I mRNA。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Uchida,K.: "Acute nephrotoxicity of a carcinogenic iron chelate selective inhibition of a proteolytic conversion of 2u-globulin to the kidney fatty acid-binding protein." FEBS Letters. 357. 165-167 (1995)
Uchida,K.:“致癌铁螯合物的急性肾毒性选择性抑制 2u-球蛋白向肾脂肪酸结合蛋白的蛋白水解转化。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ikeda,S.: "Ascorbate deficiency decreases hepatic apolopoprotein A-I mRNA in a scurvy-prone rat(genotype ODS-od/od)." Biochem.J,.submitted.
Ikeda,S.:“抗坏血酸缺乏会降低坏血病倾向大鼠(基因型 ODS-od/od)的肝载脂蛋白 A-I mRNA。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Uchida,K.: "Acute nephrotoxicity of a carcinogenic iron chelate selective inhibition of a proteolytic conversion of 2n-globulin to the Kidney fatty acid-binding protein." FEBS Letters. 357. 165-167 (1995)
Uchida,K.:“致癌铁螯合物的急性肾毒性选择性抑制 2n-球蛋白向肾脂肪酸结合蛋白的蛋白水解转化。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Identification of diabetogenic and obesity genes by using nucleotides sequence variations between SM/J and A/J mice.
  • 批准号:
    24380068
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $11.32万
  • 财政年份:
    2012
  • 负责人:
    HORIO Fumihiko
  • 依托单位:
Pioneer study on the protective effect of ascorbic acid on barrier function of gastrointestinal tract
  • 批准号:
    22658042
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
  • 资助金额:
    $2.38万
  • 财政年份:
    2010
  • 负责人:
    HORIO Fumihiko
  • 依托单位:
Identification of the diabetogenic gene and its related genes of high fat diet-induced diabetes by using novel mouse model
  • 批准号:
    21380079
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $11.98万
  • 财政年份:
    2009
  • 负责人:
    HORIO Fumihiko
  • 依托单位:
Identification of causative gene for type 2 diabetes in SMXA-5 mouse feeding a high fat diet.
海外基金